Cellular and Molecular Biology Letters - Tom 06, Numer 2B (2001) - AGRO - Yadda

Numer - szczegóły

Wydawca

-

Czasopismo

Cellular and Molecular Biology Letters

Rocznik

2001

Tom

06

Numer

2B

Identyfikatory

Okładka

Zawartość wolumenu

2B
- artykuł: p38 MAP kinase inhibitors: from biochemical tools to clinical trials (Adams J. L., Bower M. J., Boehm J. C., Gallagher T. F., Hall R., Zhao B., Lee J. C.), s. 450-451
- artykuł: Protein kinase inhibitors and antibiotic resistance (Berghuis A. M.), s. 452
- artykuł: Structural aspects of protein kinase control (Engh R. A., Bossemeyer D.), s. 453
- artykuł: How to cure diabetes without causing cancer (Cohen P.), s. 454-455
- artykuł: Chemical approaches to protein phosphorylation (Cole P. A.), s. 456
- artykuł: Small molecule irreversible inhibitors of the erbB family of transmembrane receptors (Danny W. A.), s. 457
- artykuł: Highly specific and membrane permeant peptide inhibitors of cGMP-dependent protein kinase Ialpha (Dostmann W. R. G., Nickl C. K., Taylor M. S., Brayden J. E., Frank R., Tegge W. J.), s. 458
- artykuł: Protein kinases as targets for anticancer agents: from inhibitors to useful drugs (Fabbro D.), s. 459-461
- artykuł: EGFR kinase inhibitors: it's role in diverse diseases (Frost P.), s. 462
- artykuł: Inhibition and activation of c-Src: the head and tail of a coin (Fukami Y.), s. 463-464
- artykuł: Use of protein kinase inhibitors to dissect the regulation of protein kinase B [PKB-Akt] by upstream kinases (Hill M. M., Andjelkovic M., Brazil D. P., Ferrari S., Fabbro D., Hemmings B. A.), s. 465
- artykuł: Molecular recognition and active site structure in phosphorelay signal transduction (Hoch J. A.), s. 466
- artykuł: Establishment of binding assay for protein kinase C [PKC] isozymes using synthetic C1 peptides and development of new medicinal leads with PKC isozyme and C1 domain selectivity (Irie K.), s. 467-469
- artykuł: Structure based design of a potent inhibitor of CDK2 (Davies T. G., Endicott J. A., Johnson L. N., Noble M. E. M., Arris C. E., Bentley J., Calvert A. H., Curtin N. J., Golding B. T., Griffin R. J., Hardcastle I. H., Mesguiche V., Newell H., Parsons R. J., Whitfield H. J., Boyle T., Jewsbury P.), s. 470
- artykuł: Genome wide screening for inhibitors of protein kinases (McCraith S. M., Kahn M.), s. 471
- artykuł: From consensus sequence to high affinity ligands: acquisition of signaling protein modulators (Lawrence D.), s. 472
- artykuł: Pathological angiogenesis: molecular aspects and therapeutic inhibition of endothelial receptor tyrosine kinases (Marme D.), s. 473-475
- artykuł: Pharmacological manipulation of Rho-associated kinase, ROCK (Narumiya S.), s. 476
- artykuł: Docking interactions in the map kinase cascades (Tanoue T., Nishida E.), s. 477
- artykuł: Cyclin dependent kinases as potential therapeutic target for stroke (Park D. S.), s. 478
- artykuł: Structural basis for the activity of pp60 c-src protein tyrosite kinase inhibitors (Pettitt M.), s. 479
- artykuł: Structural basis for selective inhibitors of protein kinase CK2 by ATP site-directed ligands (Sarno S., Battistutta R., de Moliner E., Meggio F., Zanotti G., Pinna L. A.), s. 480-481
- artykuł: GSK-3: A common target of extracellular stimuli and selective small molecule inhibitors that modulate glycogen metabolism and neuronal death (Reith A. D.), s. 482
- artykuł: Novel and specific Rho-kinase inhibitor, H1152P, directed against the Rho-kinase involved pathway (Sasaki Y., Ikenoya M., Yamamoto N., Suzuki M., Hidaka H.), s. 483
- artykuł: Discovery of substrates and small molecule inhibitors for a death associated protein kinase (Valentza A. V., Schumacher A. M., Weiss C., Sawkar A., Zasadzki M., Haiech J., Egli M., Watterson D. M.), s. 484-485
- artykuł: Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence-structure analysis (Wong C. F.), s. 486
- artykuł: Modulation of protein kinase signaling by protein phosphatases inhibitors (Zhang Z.-Y.), s. 487-488
- artykuł: Biochemical and functional analysis of STK during head regeneration in hydra (Cardenas M. M., Fabila Y., Salgado L. M.), s. 490
- artykuł: Extracellular signal-regulated kinase 1-2 is defense mechanism for neutrons exposed to DNA-damage (Gozdz A., Chlystun M., Hetman M.), s. 491
- artykuł: Natural versus synthetic genistein in a drug development perspective (Grynkiewicz G.), s. 492-493
- artykuł: Glycogen synthase kinase-3beta as a target for anti-apoptotic signals (Hetman M., Kaleta A., Chlystun M., Higgins M., Cavanaugh J., Xia Z.), s. 494
- artykuł: Inibition of Lyn kinase potentiates BCR-mediated signaling and proliferation (Jakies S., Lukas S., Castle B., Snow R., Moss N., Kehry M.), s. 495
- artykuł: Phosphorylation of calcyclin binding protein [CacyBP] (Jastrzebska B., Filipek A., Kuznicki J.), s. 496
- artykuł: Effect of inhibitors of polypeptide growth factor receptor tyrosine kinase on ATP synthesis in plasma membranes of human malignant tumors (Demidova V. S., Globa A. G., Karelin A. A.), s. 497
- artykuł: Effect of fibrates on branched chain alpha-ketoacid dehydrogenase [BCKDH] kinase activity (Knapik-Czajka M., Cyganek I., Wolkow P., Jaskiewicz J.), s. 498-499
- artykuł: Solvent behavior in the molecular dynamics simulations of free Cdk2 and its complexes with inhibitors (Kriz Z., Otyepka M., Koca J.), s. 500-501
- artykuł: Effect of inhibitors against the MAPK and PI3K pathways on head regeneration of hydra (Manuel G. C., Aguilera A., Salgado L. M.), s. 502
- artykuł: Molecular features of selective polyphenolic inhibitors of protein kinase CK2 (Meggio F., Moro S., Deana A. D., Ben D. D., Sarno S., Zagotto G., Pinna L. A.), s. 503-505
- artykuł: Tumor-promoting phorbol esters bind directly to the regulatory domain of diacylglicerol kinase gamma (Shindo M., Irie K., Ohigashi H., Kuriyama M., Saito N.), s. 507-508
- artykuł: Interaction of palmitoylcarnitine with protein kinase C in neurobalstoma NB-2a cells (Sobiesiak-Mirska J., Nalecz M. J., Nalecz K.), s. 509
- artykuł: Phosphorylation of RAF-1 by kinase suppressor of RAS [KSR-1] is inhibited by 'MEK-specific' inhibitors PD 098059 and U0126 in differentiating HL60 cells (Wang X., Studzinski G. P.), s. 510
- artykuł: The kinetic mechanism of the phosphorylation of a model for a transcription factor substrate by ERK2 (Waas W. F., Dalby K. N.), s. 511
- artykuł: Enzyme-linked immunosorbent assay for determination of P21-activated kinase activity (Yu J.-S., Chang S.-H., Chan W.-H., Chen H.-C.), s. 512
- artykuł: Structural and thermodynamic validation of inactive CDK2 as a template for structure-based drug design (Davies T. G., Endicot J. A., Noble M. E. M., Johnson L. N., Arris C. E., Bentley J., Boyle T., Calvert A. H., Curtin N. J., Jewsbury P. J., Gibson A. E., Golding B. T., Griffin R. J., Hardcastle I., Mesguiche V., Parsons R., Whitfield H., Newell D. R.), s. 514-515
- artykuł: Towards a PKB inhibitor (Klein S., Geiger T., Reuveni H., Livnach N., Levitzki A.), s. 516
- artykuł: A new class of p38 map kinase inhibitors that exploit a novel binding site (Moss N., Breitfelder S., Cirillo P., Gilmore T., Graham A., Hickey E., Madwed J., Moriak M., Pargellis C., Proto A., Regan J., Swinamer A., Tong L., Torcellini C.), s. 517
- artykuł: Identification of the autoinhibitory domain of PKN: construction of a selective inhibitor of the PKN family (Mukai H., Ono Y.), s. 518
- artykuł: Molecular dynamics study on tree cdk2 and its complexes with purine-like inhibitors (Otyepka M., Kriz Z., Koca J.), s. 519-521
- artykuł: Integrin-linked kinase 1 [ILK1]: a 'hot' therapeutic target (Costello P. C., Kojic D. L., Jabali M., Zhang Z., Azli L., Yoganathan N., Leung D., Yan J., Yee A., Dadhar S., Sanghera J.), s. 522
- artykuł: A novel chemical genetic approach for V-SRC substrates reveals ordered assembly of retrograde signalling pathway (Shah K.), s. 523
- artykuł: The discovery of 2-phentylamino-imidazo[4,5-h]Iso-quinolin-9-ones, a new class of inhibitors of Lck kinase with in vitro activity (Snow R. J., Butz T., Cardozo Z. G., Eckner R. J., Goldberg D. R., Hammach A., Jakes S., Kapadia S., Lukas S., Morwick T. M., Moss N., Panzenbeck M., Patel U. R., Peet G. W., Peterson J. D., Prokopowicz III.A.S., Takahashi H., Tan J. D., Tschantz M. A., Wang X.-J.Zinter R.), s. 524
- artykuł: BIBX 1382, a selective EGFR tyrosine kinase inhibitor, inhibits cell proliferation, induces cell differentation and displays anti-tumor activity against a variety of xenograft models (Solca F. F., Adolf G., Ahorn H., Baum A., Dohmann G., Hilberg F., Himmelsbach F., Metz T., van Meel J.), s. 525-526
- artykuł: Synthesis and structure -activity relationships for soluble 6-substituted 4-anilinoquinoline-3-carbonitriles. Orally active, irreversible inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor [EGFR] (Tsou H.-R., Overbeek E., Reich M. F., Floyd M. B., Johnson B. D., Gruber B. C., Ye F., Hallett W. A., Nilakatan R., Shen R., Wang Y.-F., Greenberger L. M., Wissner A.), s. 527
- artykuł: Protein ionization state prediction using a poisson-boltzmann method (Briggs J. M.), s. 531-532
- artykuł: Prediction of rates of encounter of a small molecule with a protein using a Brownian dynamics method in a continuum solvent environment (Briggs J. M.), s. 533-534
- artykuł: New leads for drug development from virtual screening (Klebe G.), s. 535
- artykuł: Docking strategies: binding of substrate and inhibitors to S-adenoslyhomocysteine hydrolase - a case study (Kuczera K., Hu Y., Yin D., Borchardt R. T.), s. 536-537
- artykuł: Free energy simulations applied to biochemical problems (Kuczera K.), s. 538-539
- artykuł: Simple model for ligand-macromolecule interactions (Rudnicki W. R., Ginalski K.), s. 540
- artykuł: Docking and scoring, exploring the limitations of understanding molecular recognition (Veith M.), s. 541
- artykuł: Modelling drug-receptor interactions starting from the sequence of a receptor (Wong C. F.), s. 542
- artykuł: Homology-derived three-dimensional strukture prediction of feruloyl esterase from Aspergillus niger (Aliwan F. O., Pickersgill R., Williamson G.), s. 544
- artykuł: Dynamic pharmacophore model development and testing (Briggs J. M., Barraca M. L., Deng J., Lee M., Lee K. W., Adesokan A.), s. 545-546
- artykuł: Molecular dynamics studies and structural analyses of alanine racemase - as a drug design target (Briggs J. M., Mustata G. I., Huang H.-C., Soares T. A.), s. 547
- artykuł: Modelling the 3D structure of protein kinase C gamma and its interaction with specific inhibitor, chelerythrine (Brodacki P., Ginalski K., Lesyng B.), s. 548
- artykuł: Quantum-mechanical calculations of the potential energy function for the phosphate transfer in model systems (Ginalski K., Grochowski P., Lesyng B.), s. 549
- artykuł: Onkogenic activation caused by poitn mutations in the kinase domain of the met proto-oncogene: molecular modeling studies (Miller M., Ginalski K., Lesyng B., Nakaigawa N., Schmidt L., Zbar B.), s. 550
- artykuł: Molecular recognition in kinases through computational chemistry (Veith M.), s. 551
- artykuł: Prediction of protonation states of phosphotyrosine in short peptides and proteins (Wojciechowski M., Grycuk T., Antosiewicz J., Lesyng B.), s. 552-553
- artykuł: Ser-Thr protein phosphatase-1 and -2A catalytic units: simulation of their interactions with selected substate and inhibitor sequences (Wozniak-Celmer E., Oldziej S., Ciarkowski J.), s. 554-556

rozwiń roczniki

JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.